| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |